Muscle spasms for NCT01217749 [clinicaltrials_resource:00000e8656f10ada35713bb2979c8956]
@en
Adjusted Mean Change From Base ...... 0118aa46e7c26af559737dc5be2b4]
@en
eligibility for clinicaltrials ...... 01abf5ed6267d2c8aa8fb45b0604a]
@en
negative pregnancy test for wo ...... 01d8e827435c8e93afb66f500fcb8]
@en
Abdominal Cramps for NCT009354 ...... 025c442238877473f032074bb726e]
@en
Number of Participants With Ov ...... 026652b72c8457ecae4232ef7819b]
@en
eligibility for clinicaltrials ...... 034aca54e0278f73c7b72fefc8f39]
@en
Overall response rate of initi ...... 036d07b2489619e85b7dcd5e0f736]
@en
7-day point prevalence smoking ...... 03aa5b9e3db40e06a7d66e7826d47]
@en
concurrent chemoradiotherapy p ...... 03d01e7c79d0213aa2f1a36628c19]
@en
Gait 12 weeks [clinicaltrials_resource:00003dcf43e1c3f68115efa8e9ce1941]
@en
No prior New York Heart Associ ...... 03e83924167ab147f1d1c1b4593d2]
@en
Dexamethasone [clinicaltrials_resource:00004030a9ebe5d5f6830bff83e982cb]
@en
serum creatinine ≤ 1.5×ULN or ...... 0411ab9e3c4561cb8829c6124638e]
@en
Esko Ruokonen, MD [clinicaltrials_resource:0000449702632e4e5d5b88428b1c285e]
@en
Doczero [clinicaltrials_resource:0000479ef685db9bbf5ad98ac3d11cf4]
@en
Hemoglobin < 12.0 g/dL [clinicaltrials_resource:00004f03d23b4d71b15234f2e1863411]
@en
Stephen Robinson, FRCP, MD [clinicaltrials_resource:00005798f671f645ac3b79153a68b763]
@en
Antibody Concentrations Agains ...... 057dd7c420208c0b09c4fdc3fcf19]
@en
Chemotherapy/Cell ...... 05bb5a8a13d989221656efc37828d]
@en
Time to Last Unformed Stool (T ...... 05ec47c408d18cf469b6bfc96c212]
@en
6-month Progression-free Survi ...... 064868dd7d872c050c90eb2d4ab96]
@en
Myocardial infarction for NCT0 ...... 066de1c8074e05477b17c22f20daa]
@en
Alcohol poisoning for NCT00492 ...... 06c6a2177b9e898c95051d822e5bd]
@en
Fungal infection for NCT004607 ...... 06ff798dc8469f2dcbc0a731733c5]
@en
HAMD-17 total score at week 8. ...... 077b7624960148a0e79c37e613806]
@en
[clinicaltrials_resource:00007f016afdb489841b85355589b969]
@en
Randall R. Rule, PhD [clinicaltrials_resource:000085c7d0b1239ccf88c845fd1c0082]
@en
Asthenia for NCT00833638 [clinicaltrials_resource:000086644bb19222b711fa8acacc3d33]
@en
Persistance and adherence to t ...... 0877790ab42df9b393fc0772dd1b4]
@en
Daily GC (prednisone or deflaz ...... 0907adbe4924012b8acaf5fe7481b]
@en
Oedema, Pulmonary [clinicaltrials_resource:000096cc1e8e591fdddd5b90037b369b]
@en
Pyelonephritis for NCT01183013 [clinicaltrials_resource:000097011233c2c2ae3769cc1db63e0c]
@en
clinicaltrials:NCT00955383 stu ...... 0a927a89929d9e25957fee1d004a1]
@en
Abnormal electrocardiogram wit ...... 0b2f11bbe7d9c32ae396cacebeee8]
@en
clinical results for clinicalt ...... 0b40bab963f64766737680acfe895]
@en
Modified Mayo Score indicating ...... 0b6f1b6b4d159c16e3abcf84587cf]
@en
eligibility for clinicaltrials ...... 0b7a84af0c468b75fac24df4074c8]
@en
(2)Fatty liver was diagnosed b ...... 0bbd49a0f79c3cb6904d48e52bf86]
@en
Arun Rao [clinicaltrials_resource:0000bc73ada51aac863a10597a3ba978]
@en
Proellex 25 mg [clinicaltrials_resource:0000bd6e51a7d13f5469f8589d7f74f8]
@en
Voluntary consent before perfo ...... 0c00b9d767b503bdcd78094f6a03f]
@en
eligibility for clinicaltrials ...... 0c1bc1b31ac304c8650d33450ca87]
@en
Subunit or killed vaccines wit ...... 0c36e350001ffb49411d675a4ae2e]
@en
Lymphopenia for NCT01001221 [clinicaltrials_resource:0000c4a319b4987a25153894191a14bd]
@en
The Ottawa Hospital [clinicaltrials_resource:0000d16a0662329f460d942e0f2c06cd]
@en
[clinicaltrials_resource:0000d3e752cd3c473609f591ea0a2d3d]
@en
Overall survival [clinicaltrials_resource:0000d6976b16ff864d4a4a05aa483f45]
@en
Weight < 120 kg [clinicaltrials_resource:0000d9d4d6233a44a99f07abd5dcd1de]
@en
Maximum Reading Speed Month 12 [clinicaltrials_resource:0000e5bcaaa80cc7b1f88125dca72c9a]
@en